ciglitazone has been researched along with Allergic Reaction in 1 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahten, A | 1 |
| Koch, C | 1 |
| Ernst, D | 1 |
| Schnöller, C | 1 |
| Hartmann, S | 1 |
| Worm, M | 1 |
1 other study available for ciglitazone and Allergic Reaction
| Article | Year |
|---|---|
Systemic PPARgamma ligation inhibits allergic immune response in the skin.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dermatitis, Atopic; Disease Models, | 2008 |